1. Home
  2. BLRX vs AACG Comparison

BLRX vs AACG Comparison

Compare BLRX & AACG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • AACG
  • Stock Information
  • Founded
  • BLRX 2003
  • AACG 1999
  • Country
  • BLRX Israel
  • AACG China
  • Employees
  • BLRX N/A
  • AACG N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • AACG Other Consumer Services
  • Sector
  • BLRX Health Care
  • AACG Real Estate
  • Exchange
  • BLRX Nasdaq
  • AACG Nasdaq
  • Market Cap
  • BLRX 36.0M
  • AACG 31.9M
  • IPO Year
  • BLRX 2011
  • AACG N/A
  • Fundamental
  • Price
  • BLRX $0.20
  • AACG $0.81
  • Analyst Decision
  • BLRX Strong Buy
  • AACG
  • Analyst Count
  • BLRX 2
  • AACG 0
  • Target Price
  • BLRX $5.50
  • AACG N/A
  • AVG Volume (30 Days)
  • BLRX 2.2M
  • AACG 24.8K
  • Earning Date
  • BLRX 11-25-2024
  • AACG 11-07-2024
  • Dividend Yield
  • BLRX N/A
  • AACG N/A
  • EPS Growth
  • BLRX N/A
  • AACG N/A
  • EPS
  • BLRX N/A
  • AACG N/A
  • Revenue
  • BLRX $21,991,000.00
  • AACG $35,747,843.00
  • Revenue This Year
  • BLRX N/A
  • AACG N/A
  • Revenue Next Year
  • BLRX N/A
  • AACG N/A
  • P/E Ratio
  • BLRX N/A
  • AACG N/A
  • Revenue Growth
  • BLRX N/A
  • AACG 15.80
  • 52 Week Low
  • BLRX $0.19
  • AACG $0.50
  • 52 Week High
  • BLRX $1.70
  • AACG $1.65
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 24.20
  • AACG 29.79
  • Support Level
  • BLRX $0.23
  • AACG $0.94
  • Resistance Level
  • BLRX $0.56
  • AACG $0.92
  • Average True Range (ATR)
  • BLRX 0.03
  • AACG 0.05
  • MACD
  • BLRX -0.00
  • AACG -0.01
  • Stochastic Oscillator
  • BLRX 7.26
  • AACG 3.80

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About AACG ATA Creativity Global

ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments are Overseas art study services, Other educational services and K-12 education assessment and other services. Majority of its revenue comes from Overseas art study services.

Share on Social Networks: